Renishaw plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2016; Provides Earnings Guidance for the Full Year of Fiscal 2017; Maintains Interim Dividend for the Six Months Ended December 31, 2016, Payable on April 7, 2017
January 26, 2017 at 02:00 am
Share
Renishaw plc reported unaudited consolidated earnings results for the six months ended December 31, 2016. For the six months, the company reported revenue of £240.424 million compared to £198.488 million a year ago. Operating profit was £35.568 million compared to £28.455 million a year ago. Profit before taxation was £35.694 million compared to £28.595 million a year ago. Profit for the period from continuing operations was £29.733 million compared to £23.313 million a year ago. Profit attributable to equity shareholders of the parent company was £26.360 million compared to £22.381 million a year ago. Basic and diluted earnings per share from continuing operations were 41 pence compared to 32.4 pence a year ago. Cash flows from operating activities were £51.327 million compared to £13.072 million a year ago. Purchase of property, plant and equipment was £25.896 million compared to £28.734 million a year ago. Purchase of other intangibles was £0.080 million compared to £0.401 million a year ago.
The Board remains confident in the future prospects of the Group. The company continues to anticipate growth in both revenue and profit in this financial year and expect full year revenue to be in the range of £500 million to £530 million and profit before tax to be in the range of £85 million to £105 million.
The company maintained interim dividend of 12.5 pence net per share will be paid on April 7, 2017 to shareholders on the register on 10th March 2017.
Renishaw plc is a United Kingdom-based supplier of measuring systems and production systems. The principal activities of the Company are the design, manufacture, sale, distribution and service of manufacturing technologies products and services, and analytical instruments and medical devices. The Company operates through two segments: manufacturing technologies, and analytical instruments and medical devices. The manufacturing technologies segment consists of four areas: industrial metrology, additive manufacturing, position measurement and the new industrial automation line. The analytical instruments and medical devices segment consist of spectroscopy and neurological, where it supplies its customers with technologies to improve materials analysis and neurological therapies. Its products include CMM probes, software, and retrofits; equator gauging system; interferometric laser encoders; probing and tool measurement systems for machine tools, and others.
Renishaw plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended December 31, 2016; Provides Earnings Guidance for the Full Year of Fiscal 2017; Maintains Interim Dividend for the Six Months Ended December 31, 2016, Payable on April 7, 2017